Julie Atkin

Dr. Julie Atkin

Department of Biomedical Sciences, Macquarie University, Sydney, Australia
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2014 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
MFManal A. Farg
Manal A. Farg
VSVinod Sundaramoorthy
Vinod Sundaramoorthy
JSJessica M. Sultana
Jessica M. Sultana
SYShu Yang
Shu Yang
RARachel A.K. Atkinson
Rachel A.K. Atkinson
Julie AtkinJulie Atkin
Julie Atkin
Intronic expansion of a hexanucleotide GGGGCC repeat in the chromosome 9 open reading frame 72 (C9ORF72) gene is the major cause of familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. However, the cellular function of the C9ORF72 protein remains unknown. Here, we demonstrate that C9ORF72 regulates endosomal trafficking. C9ORF72 colocalized with Rab proteins implicated in autophagy and endocytic transport: Rab1, Rab5, Rab7 and Rab11 in neuronal cell lines, primary cortical neurons and human spinal cord motor neurons, consistent with previous predictions that C9ORF72 bears Rab guanine exchange factor activity. Consistent with this notion, C9ORF72 was present in the extracellular space and as cytoplasmic vesicles. Depletion of C9ORF72 using siRNA inhibited transport of Shiga toxin from the plasma membrane to Golgi apparatus, internalization of TrkB receptor and altered the ratio of autophagosome marker light chain 3 (LC3) II:LC3I, indicating that C9ORF72 regulates endocytosis and autophagy. C9ORF72 also colocalized with ubiquilin-2 and LC3-positive vesicles, and co-migrated with lysosome-stained vesicles in neuronal cell lines, providing further evidence that C9ORF72 regulates autophagy. Investigation of proteins interacting with C9ORF72 using mass spectrometry identified other proteins implicated in ALS; ubiquilin-2 and heterogeneous nuclear ribonucleoproteins, hnRNPA2/B1 and hnRNPA1, and actin. Treatment of cells overexpressing C9ORF72 with proteasome inhibitors induced the formation of stress granules positive for hnRNPA1 and hnRNPA2/B1. Immunohistochemistry of C9ORF72 ALS patient motor neurons revealed increased colocalization between C9ORF72 and Rab7 and Rab11 compared with controls, suggesting possible dysregulation of trafficking in patients bearing the C9ORF72 repeat expansion. Hence, this study identifies a role for C9ORF72 in Rab-mediated cellular trafficking.

1 June 2008 in Neurobiology of Disease
Verified
Journal Article
Closed access
Julie AtkinJulie Atkin
Julie Atkin
MFManal A. Farg
Manal A. Farg
AWAdam K. Walker
Adam K. Walker
CMCatriona McLean
Catriona McLean
DTDoris Tomas
Doris Tomas
MHMalcolm K. Horne
Malcolm K. Horne

1 October 2006 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Julie AtkinJulie Atkin
Julie Atkin
MFManal A. Farg
Manal A. Farg
Bradley TurnerBradley Turner
Bradley Turner
DTDoris Tomas
Doris Tomas
JLJudith A. Lysaght
Judith A. Lysaght
MHMalcolm K. Horne
Malcolm K. Horne
Mutations in Cu/Zn superoxide dismutase (SOD1) are linked to motor neuron death in familial amyotrophic lateral sclerosis (ALS) by an unclear mechanism, although misfolded SOD1 aggregates are commonly associated with disease. Proteomic analysis of the transgenic SOD1G93A ALS rat model revealed significant up-regulation of endoplasmic reticulum (ER)-resident protein-disulfide isomerase (PDI) family members in lumbar spinal cords. Expression of SOD1 mutants (mSOD1) led to an up-regulation of PDI in motor neuron-like NSC-34 cells but not other cell lines. Inhibition of PDI using bacitracin increased aggregate production, even in wild type SOD1 transfectants that do not readily form inclusions, suggesting PDI may protect SOD1 from aggregation. Moreover, PDI co-localized with intracellular aggregates of mSOD1 and bound to both wild type and mSOD1. SOD1 was also found in the microsomal fraction of cells despite being a predominantly cytosolic enzyme, confirming ER-Golgi-dependent secretion. In SOD1G93A mice, a significant up-regulation of unfolded protein response entities was also observed during disease, including caspase-12, -9, and -3 cleavage. Our findings therefore implicate unfolded protein response and ER stress-induced apoptosis in the patho-physiology of familial ALS. The possibility that PDI may be a therapeutic target to prevent SOD1 aggregation is also raised by this study.

9 October 2019 in Glia
Verified
Journal Article
Closed access
PDF file
VDVandana Deora
Vandana Deora
JLJohn D. Lee
John D. Lee
EAEduardo A. Albornoz
Eduardo A. Albornoz
LMLuke McAlary
Luke McAlary
CJCyril J. Jagaraj
Cyril J. Jagaraj
TWTrent M. Woodruff
Trent M. Woodruff

27 June 2019 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
ARAudrey M. G. Ragagnin
Audrey M. G. Ragagnin
SSSina Shadfar
Sina Shadfar
MVMarta Vidal
Marta Vidal
SJShafi Jamali
Shafi Jamali
Julie AtkinJulie Atkin
Julie Atkin
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the death of both upper and lower motor neurons (MNs) in the brain, brainstem and spinal cord. The neurodegenerative mechanisms leading to MN loss in ALS are not fully understood. Importantly, the reasons why MNs are specifically targeted in this disorder are unclear, when the proteins associated genetically or pathologically with ALS are expressed ubiquitously. Furthermore, MNs themselves are not affected equally; specific MNs subpopulations are more susceptible than others in both animal models and human patients. Corticospinal MNs and lower somatic MNs, which innervate voluntary muscles, degenerate more readily than specific subgroups of lower MNs, which remain resistant to degeneration, reflecting the clinical manifestations of ALS. In this review, we discuss the possible factors intrinsic to MNs that render them uniquely susceptible to neurodegeneration in ALS. We also speculate why some MN subpopulations are more vulnerable than others, focusing on both their molecular and physiological properties. Finally, we review the anatomical network and neuronal microenvironment as determinants of MN subtype vulnerability and hence the progression of ALS.

15 April 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
KWKelly L. Williams
Kelly L. Williams
STSimon Topp
Simon Topp
SYShu Yang
Shu Yang
BSBradley Smith
Bradley Smith
JFJennifer A. Fifita
Jennifer A. Fifita
IBIan Blair
Ian Blair
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are overlapping, fatal neurodegenerative disorders in which the molecular and pathogenic basis remains poorly understood. Ubiquitinated protein aggregates, of which TDP-43 is a major component, are a characteristic pathological feature of most ALS and FTD patients. Here we use genome-wide linkage analysis in a large ALS/FTD kindred to identify a novel disease locus on chromosome 16p13.3. Whole-exome sequencing identified aCCNFmissense mutation at this locus. Interrogation of international cohorts identified additional novelCCNFvariants in familial and sporadic ALS and FTD. Enrichment of rare protein-alteringCCNFvariants was evident in a large sporadic ALS replication cohort.CCNFencodes cyclin F, a component of an E3 ubiquitin–protein ligase complex (SCFCyclin F). Expression of mutantCCNFin neuronal cells caused abnormal ubiquitination and accumulation of ubiquitinated proteins, including TDP-43 and a SCFCyclin Fsubstrate. This implicates common mechanisms, linked to protein homeostasis, underlying neuronal degeneration.